973.726.4858
973.615.3900
 
  Realistic Assessments • Experienced Insights • Practical Recommendations    
 
   
 
     
A client’s leading potential aquisition was being auctioned by a merchant bank, R&S’s analysis showed over-inflated value and potential unreported conflicts in the data presented. Their client passed, and so did the competition. For more details, call 973.726.4858.
A 2nd generation medical device was ready but the 1st generation was still unaccepted in the market, so the principals identified a new use, opening the flood gates. Find out more by calling 973.726.4858.
A large medical device company wanted projections for a new surgical technology. Despite huge hype, R&S’s projected growth curve and analysis suggested a “wait policy” which competitors now wish they had followed. Don’t wait, call now for the whole story 973.726.4858.
A team approach developed a study that unveiled a $1 billion opportunity in the cosmetic procedure market, giving a technology licensing company the confidence to form a new commercialized subsidiary. Learn what was unique about this study: call 973.726.4858.
An R&S segmentation study identified market potential, competitive assessment, and critical mass of the most advantageous entry strategy for a Fortune 100 medical company. Learn how the various entry strategies were significantly different: call 973.726.4858.
Thought leader interviews pointed the way towards a clinical study and the price recommendations proposed by our principals so that payers would accept the fees for a new physician service. Payer, Provider, or Patient—who is the driver in today’s market for your product: call 973.726.4858.
Not every great product is economically viable, but an R&S study, development plan, and analysis cleared the way for a new anti-inflammatory compound. Figure out what made a difference by calling 973.726.4858.
From a list of 100s, six potential synergistic acquisition candidates were identified for a Fortune 100 medical device company. Call 973.726.4858 for the whole scoop on how this was possible.
R&S insights cut through perceptually conflicting information to identify current technology that not only pre-empted proposed applications of industry “thought leaders,” but prevented their client from making a multi-million dollar mistake based on inaccurate conclusions. Ask better questions, get better answers: call 973.726.4858 for all the details.
Want examples of our impact?
Accurate acquisition valuation
Maximizing pipeline
management
When to pull the plug
Commercialize vs. out-license technology
Ultimate market entry strategy
Maximize payer reimbursement
Evaluating financial viability
Identifying realistic acquisition targets
Turn “data” into insightful information
 
  Learn more…
right arrow Contact us and let’s get started
right arrow Find out more about what we do
right arrow Meet us in detail: information on Bob and Steve
 

When should you use Roberts and Stephens to help your company compete in the medical marketplace?

The answer is simple—whenever your company has questions about products, investments or changes in the medical market place, or is facing questions like these:

  • Should we invest or divest to maximize our in-market and pipeline therapeutic portfolio?… and if so, where?
  • What’s the greatest opportunity for our medical products and technology?
  • Can we perform an evaluation of market potential for a given indication or procedure to better understand the return on investment for commercialization?
  • Do we have a realistic economic positioning for our products’ scientific or clinical value?
  • How do we bridge the physician-payer price disconnect to make solid pricing decisions?
  • Does our technology really represent game-changing potential from either a clinical or healthcare economics perspective?
  • How can we translate our “data” into breakthrough decision driving information?
  • How do I find the time and resources to conduct this analysis to the degree where I am confident in the results?
  • What should we do about…?”

Why will you be glad you considered Roberts & Stephens to help get the answers?

First, because we only focus on the medical industry. We know what to look for and where to get the right answers. And second, because we offer a unique combination of comprehensive analysis, breakthrough insights and unparalleled success. You’ll get accurate, actionable answers to your questions, not just a dump of information. (If this isn’t what you’re looking for, we suggest you try someone else.)

Our approach is not complicated, but it is different… and successful:

It starts and ends by working directly with our principals: Bob Lieberman and Steve Pincus, who bring 40 years of combined experience in market strategy, industry insight and tactical analysis. In between, we utilize our hard-line criteria of success: meeting bottom-line measurements of ROI, market penetration and pre-emptive, long-term impact consistent with your company’s vision and culture.

But don’t call us if…

  1. It has nothing to do with healthcare.
  2. It is an IT problem.
  3. You “already know the answer”.
  4. You are looking for young hunks to handle the assignment.

However, if you’re serious about solving your challenges, call us today and let’s begin finding your answers.